DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

被引：0
|
作者：
Capecchi, M. [1 ]
Corradini, P. [1 ]
Montefusco, V. [1 ]
机构：
[1] Ist Nazl Tumori, Ematol Trapianto Midollo Osseo, Milan, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1983
引用
收藏
页码：795 / 796
页数：2
相关论文
共 50 条
  • [31] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    David S. Siegel
    Gary J. Schiller
    Christy Samaras
    Michael Sebag
    Jesus Berdeja
    Siddhartha Ganguly
    Jeffrey Matous
    Kevin Song
    Christopher S. Seet
    Giampaolo Talamo
    Mirelis Acosta-Rivera
    Michael Bar
    Donald Quick
    Bertrand Anz
    Gustavo Fonseca
    Donna Reece
    William E. Pierceall
    Weiyuan Chung
    Faiza Zafar
    Amit Agarwal
    Nizar J. Bahlis
    Leukemia, 2020, 34 : 3286 - 3297
  • [32] Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma
    Moustafa, Muhamad Alhaj
    Parrondo, Ricardo
    Abdulazeez, Mays F.
    Roy, Vivek
    Sher, Taimur
    Alegria, Victoria R.
    Warsame, Rahma M.
    Fonseca, Rafael
    Rasheed, Ahsan
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Kapoor, Prashant
    Buadi, Francis K.
    Dingli, David
    Hayman, Suzanne R.
    Reeder, Craig B.
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    ANTI-CANCER DRUGS, 2024, 35 (01) : 63 - 69
  • [33] Combination of ixazomib, pomalidomide and dexamethasone in the treatment of multiple myeloma in relapse and refractory to lenalidomide
    Stocker, Nicolas
    HEMATOLOGIE, 2018, 24 (04): : 261 - 262
  • [34] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Pierceall, William E.
    Chung, Weiyuan
    Zafar, Faiza
    Agarwal, Amit
    Bahlis, Nizar J.
    LEUKEMIA, 2020, 34 (12) : 3286 - 3297
  • [35] An audit of thromboprophylaxis for patients with myeloma on the immunomodulatory therapies: thalidomide, lenalidomide or pomalidomide
    Melly, M.
    Al-Talib, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 186 - 186
  • [36] Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
    K Detweiler Short
    S V Rajkumar
    D Larson
    F Buadi
    S Hayman
    A Dispenzieri
    M Gertz
    S Kumar
    J Mikhael
    V Roy
    R A Kyle
    M Q Lacy
    Leukemia, 2011, 25 : 906 - 908
  • [37] The Demographics and Outcomes of Patients with Multiple Myeloma Dual Refractory to or Intolerant of Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide
    Wang, Tzu-Fei
    Fiala, Mark
    Ahluwalia, Rohan
    Trinkaus, Kathryn
    Moliske, Caitlin
    Cox, Doug
    Jaenicke, Matthew
    Stockerl-Goldstein, Keith
    Wildes, Tanya
    Carson, Kenneth R.
    Tomasson, Michael H.
    Vij, Ravi
    BLOOD, 2012, 120 (21)
  • [38] The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
    Wang, Tzu-Fei
    Ahluwalia, Rohan
    Fiala, Mark A.
    Trinkaus, Kathryn M.
    Cox, Doug P.
    Jaenicke, Matthew
    Moliske, Caitlin C.
    Carson, Kenneth R.
    Wildes, Tanya M.
    Tomasson, Michael H.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 337 - 341
  • [39] A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
    Huang, Shang-Yi
    Yu, Yuan-Bin
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Wang, Ming-Chung
    Lin, Hsuan-Yu
    Lin, Sheng-Fung
    Lin, Tseng-Hsi
    Hua, Ye
    Puccio-Pick, Marie
    DeMarco, Dena
    Jacques, Christian
    Dunn, Po
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (09) : 705 - 710
  • [40] Pomalidomide-dexamethasone combination is efficient in lenalidomide-refractory multiple myeloma
    Coman, Tereza
    HEMATOLOGIE, 2010, 16 (06): : 410 - 411
12345